Patients over 65 years with Acute Complicated Calculous Biliary Disease are Treated Differently-Results and Insights from the ESTES Snapshot Audit.
Gary A Bass, Amy E Gillis, Yang Cao...
https://pubmed.ncbi.nlm.nih.gov/33813631/Actively Recruiting
Led by Helsinki University Central Hospital · Updated on 2025-10-07
400
Participants Needed
12
Research Sites
52 weeks
Total Duration
This research aims to compare the safety and effectiveness of laparoscopic cholecystectomy versus a wait-and-see approach in elderly patients who have had common bile duct stones successfully removed using endoscopy. The study focuses on patients 75 years and older, including those with additional health issues, to determine if avoiding surgery is as safe as performing cholecystectomy. The main measurement is a combined outcome of death, serious complications, or recurring biliary problems within one year after randomization. Participants are randomly assigned to one of two groups one will have laparoscopic cholecystectomy within two weeks following stone removal, and the other will be managed without surgery but can have cholecystectomy later if needed. The study includes an interim safety check after the first 100 participants, with a plan to stop early if significant differences arise. Both groups are monitored over time to assess health outcomes and complications. During the study, participants will be followed for at least one year to track outcomes such as survival, complications, biliary events, quality of life, pain, and healthcare costs. Assessments occur at various intervals, including 30, 180, and 365 days after randomization. Researchers will evaluate these factors carefully to understand the benefits and risks of each approach, ensuring participant safety throughout the trial.
CONDITIONS
ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly
P
Panu Mentula, MD, PhD
P
Päivi Siironen, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Helsinki University Central Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 weeks after randomization
Participants receive laparoscopic cholecystectomy within 2 weeks after endoscopic removal of common bile duct stones or are managed with a wait-and-see approach.
1 baseline visit and multiple follow-up visits up to 1 year
Duration - Up to 2 years
Participants are monitored for outcomes including complications, recurrent biliary events, and survival for up to 2 years after randomization.
Visits at 30 days, 180 days, 365 days, and additional assessments up to 2 years
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Gary A Bass, Amy E Gillis, Yang Cao...
https://pubmed.ncbi.nlm.nih.gov/33813631/Antti Kivivuori, Laura Mattila, Antti Siiki...
https://pubmed.ncbi.nlm.nih.gov/36524923/Djemila Boerma, Erik A J Rauws, Yolande C A Keulemans...
https://pubmed.ncbi.nlm.nih.gov/12241833/R Costi, D DiMauro, A Mazzeo...
https://pubmed.ncbi.nlm.nih.gov/17111279/Helsinki University Central Hospital
Lead Sponsor